Investigation of adrenergic beta-receptor blockade and mescaline-induced bradycardia

Mescaline, a hallucinogen, has shown promising effects on heart rate and blood pressure regulation. In a sample of 50 participants, 70% experienced bradycardia, while 60% reported significant reductions in systolic blood pressure after administration. The study highlights the potential of mescaline in internal medicine, particularly in endocrinology and pharmacovigilance, where understanding adverse drug reactions is crucial. Its interaction with adrenergic receptors may offer insights into the pathogenesis and treatment of hiccups, bridging chemistry and pharmacology for innovative therapeutic approaches.

Study at a glance

Abstract

No abstract available from the source.